We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Pharmaceutical production has been a Tanzanian industrial success, generating skills and employment and access to essential medicines
This brief presents some trends and developments of the Kenyan pharmaceutical industry
Register as a manufacturer, importer or distributor of active substances.
The report presents a review of the evaluation of environmental risks posed by human pharmaceuticals.
Second Pharmaceuticals in the Environment (PiE) Group meeting held with continued focus on imidacloprid and fipronil.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
British Pharmacopoeia (BP) provides official standards for pharmaceutical substances and medicinal products. British Pharmacopoeia Commission is an advisory non-departmental public body, sponsored by the Department of Health and Social Care .
Webinars for pharmaceutical companies, clinical trial sponsors, e-cigarette producers and brokers of medicinal products
How to manage trade taxation policy in such a way that public revenue can be acquired but not at the cost of long term industrialisation
Directions given by the Secretary of State for Health under powers conferred by statute.
'Urban bias' in access to imported medicines in Tanzania and its policy implications
Regulators must use this process guidance note (PGN) to assess applications and write permits for the formulation and finishing of pharmaceutical products
Ways to link technology, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines
Findings from the review of regulatory enforcement in the pharmaceutical sector.
Crescent Pharma Limited has informed the MHRA regarding an error with the European Article Number (EAN) barcode on the cartons of the above-mentioned batches of Pantoprazole 40 mg Gastro-Resistant Tablets distributed by Crescent Pharma Limited.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).